Nasdaq Clsn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq clsn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Clsn Today - Breaking & Trending Today

Celsion Corporation Presentation Time at the H.C.

LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr.. ....

Corinne Le Goff , Le Goff , Celsion Corporation , Jeffreyw Church , Lotte New York Palace Hotel , Chief Executive Officer , Annual Global Investment Conference , Lotte New York Palace , Vice President , Nasdaq Clsn , Celsion Corporation , Nasdaq Clsn , Clinical Stage , Drug Development Company , Hc Wainwright , Rna Based Therapies , Rna Therapies ,

Celsion Appoints Dr. Corinne Le Goff as President and Chief

Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) Celsion Corporation (NASDAQ:. ....

United States , France General , Hong Kong , Michaelh Tardugno , Corinne Le Goff , Le Goff , Celsion Corporation , Company Board Of Directors , Rene Descartes University , Jeffreyw Church , Longboard Pharmaceuticals , Healthcare Leadership Council , Exchange Commission , Sorbonne University , Roche Group , Northwestern University , Hong Kong University Of Science , Executive Chairman , Chief Executive Officer , Chief Commercial Officer , Senior Vice President , Global Product Strategy , Commercial Innovation , Europe Region , Healthcare Leadership , Roche France ,

Celsion Co. (NASDAQ:CLSN) Short Interest Down 22.8% in May

Celsion Co. (NASDAQ:CLSN – Get Rating) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 137,400 shares, a decline of 22.8% from the April 30th total of 177,900 shares. Based on an average daily volume of 319,600 shares, the days-to-cover […] ....

Celsion Company Profile Get Rating , Celsion Corporation , Celsion Co , Virtu Financial , Investment Advisers , Renaissance Technologies , Get Rating , Street Group , Two Sigma Advisers , Company Profile , Nasdaq Clsn ,

Celsion (NASDAQ:CLSN) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright assumed coverage on shares of Celsion in a research note on Tuesday. They set a “buy” rating and a $16.00 target price on […] ....

Morgan Stanley , Geode Capital Management , Celsion Corporation , Renaissance Technologies , Millennium Management , Get Rating , Capital Management , Sigma Advisers , Nasdaq Clsn , Initiated Coverage , Stocknews Com ,

Zacks: Analysts Anticipate Celsion Co. (NASDAQ:CLSN) Will Announce Earnings of -$0.94 Per Share

Wall Street analysts predict that Celsion Co. (NASDAQ:CLSN – Get Rating) will report earnings of ($0.94) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Celsion’s earnings, with the lowest EPS estimate coming in at ($1.08) and the highest estimate coming in at ($0.77). Celsion posted earnings per […] ....

Morgan Stanley , Celsion Corporation , Virtu Financial , Zacks Investment Research , Renaissance Technologies , Capital Partners , Celsion Co , Millennium Management , Wall Street , Get Rating , Nasdaq Clsn ,